149 related articles for article (PubMed ID: 8197746)
1. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
Seiser A; Pötzl G; Safoschnik G; Pichler S; Bernheimer H; Schwerer B
Wien Klin Wochenschr; 1994; 106(6):159-63. PubMed ID: 8197746
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
4. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
Koga M; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
[TBL] [Abstract][Full Text] [Related]
5. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
[TBL] [Abstract][Full Text] [Related]
6. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
7. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
8. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
9. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S
Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
11. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
14. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
[TBL] [Abstract][Full Text] [Related]
15. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
16. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
[TBL] [Abstract][Full Text] [Related]
18. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
19. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
20. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
